KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $10.9 million.

  • Biolife Solutions' Accumulated Expenses rose 2906.85% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 2906.85%. This contributed to the annual value of $12.5 million for FY2024, which is 3650.92% up from last year.
  • As of Q3 2025, Biolife Solutions' Accumulated Expenses stood at $10.9 million, which was up 2906.85% from $9.3 million recorded in Q2 2025.
  • Biolife Solutions' 5-year Accumulated Expenses high stood at $12.5 million for Q4 2024, and its period low was $6.7 million during Q1 2022.
  • Moreover, its 5-year median value for Accumulated Expenses was $9.1 million (2023), whereas its average is $9.2 million.
  • Per our database at Business Quant, Biolife Solutions' Accumulated Expenses soared by 28031.47% in 2021 and then plummeted by 3830.97% in 2022.
  • Biolife Solutions' Accumulated Expenses (Quarter) stood at $9.4 million in 2021, then rose by 4.09% to $9.8 million in 2022, then fell by 6.76% to $9.1 million in 2023, then skyrocketed by 36.51% to $12.5 million in 2024, then fell by 12.42% to $10.9 million in 2025.
  • Its Accumulated Expenses was $10.9 million in Q3 2025, compared to $9.3 million in Q2 2025 and $8.2 million in Q1 2025.